AI Expedites Breast Cancer Diagnosis
Analysis based on 6 articles · First reported Jun 02, 2026 · Last updated Jun 03, 2026
This medical breakthrough is expected to positively impact the healthcare and biotechnology industries by improving diagnostic efficiency and patient outcomes. Companies involved in AI development for medical applications, as well as healthcare providers adopting such technologies, could see increased demand and improved operational metrics.
Researchers from University of California, San Francisco and University of California, Berkeley have developed and applied an open-source AI model called Mirai to significantly reduce wait times for breast cancer diagnosis. The model, co-developed by Adam Yala>>> and clinically applied by Maggie Chi>>>, triages women with abnormal mammograms, allowing high-risk patients at San Francisco General Hospital>>> to undergo diagnostic evaluations and even biopsies within a single day. This reduces diagnostic wait times from weeks to hours and biopsy waits from months to days, fostering a more personalized and expedited approach to breast cancer care. The study, funded by the United States — National Institutes of Health>>>, was published in Nature Digital Medicine>>>.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard